These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34348744)

  • 1. 10 years of CEMARA database in the AnDDI-Rares network: a unique resource facilitating research and epidemiology in developmental disorders in France.
    Messiaen C; Racine C; Khatim A; Soussand L; Odent S; Lacombe D; Manouvrier S; Edery P; Sigaudy S; Geneviève D; Thauvin-Robinet C; Pasquier L; Petit F; Rossi M; Willems M; Attié-Bitach T; Roux-Levy PH; Demougeot L; Slama LB; Landais P; ; Jannot AS; Binquet C; Sandrin A; Verloes A; Faivre L
    Orphanet J Rare Dis; 2021 Aug; 16(1):345. PubMed ID: 34348744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEMARA an information system for rare diseases.
    Landais P; Messiaen C; Rath A; Le Mignot L; Dufour E; Ben Said M; Jais JP; Toubiana L; Baujat G; Bourdon-Lanoy E; Gérard-Blanluet M; Bodemer C; Salomon R; Aymé S; Le Merrer M; Verloes A;
    Stud Health Technol Inform; 2010; 160(Pt 1):481-5. PubMed ID: 20841733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of patients' cohorts in the French National rare disease registry.
    Pichon T; Messiaen C; Soussand L; Angin C; Sandrin A; Elarouci N; Jannot AS;
    Orphanet J Rare Dis; 2023 Jul; 18(1):176. PubMed ID: 37400917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEMARA: a Web dynamic application within a N-tier architecture for rare diseases.
    Messiaen C; Le Mignot L; Rath A; Richard JB; Dufour E; Ben Said M; Jais JP; Verloes A; Le Merrer M; Bodemer C; Baujat G; Gerard-Blanluet M; Bourdon-Lanoy E; Salomon R; Ayme S; Landais P
    Stud Health Technol Inform; 2008; 136():51-6. PubMed ID: 18487707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research.
    Choquet R; Maaroufi M; de Carrara A; Messiaen C; Luigi E; Landais P
    J Am Med Inform Assoc; 2015 Jan; 22(1):76-85. PubMed ID: 25038198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.
    De Antonio M; Dogan C; Daidj F; Eymard B; Puymirat J; Mathieu J; Gagnon C; Katsahian S; ; Hamroun D; Bassez G
    Orphanet J Rare Dis; 2019 Jun; 14(1):122. PubMed ID: 31159885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of rare diseases of the Head, Neck and Teeth: results of a French population-based prospective 8-year study.
    Friedlander L; Choquet R; Galliani E; de Chalendar M; Messiaen C; Ruel A; Vazquez MP; Berdal A; Alberti C; De La Dure Molla M
    Orphanet J Rare Dis; 2017 May; 12(1):94. PubMed ID: 28526043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coding undiagnosed rare disease patients in health information systems: recommendations from the RD-CODE project.
    Angin C; Mazzucato M; Weber S; Kirch K; Abdel Khalek W; Ali H; Maiella S; Olry A; Jannot AS; Rath A
    Orphanet J Rare Dis; 2024 Jan; 19(1):28. PubMed ID: 38280999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.
    Villeneuve L; Passot G; Glehen O; Isaac S; Bibeau F; Rousset P; Gilly FN;
    Orphanet J Rare Dis; 2017 Feb; 12(1):37. PubMed ID: 28212684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epidemiology of Transition into Adulthood of Rare Diseases Patients: Results from a Population-Based Registry.
    Mazzucato M; Visonà Dalla Pozza L; Minichiello C; Manea S; Barbieri S; Toto E; Vianello A; Facchin P
    Int J Environ Res Public Health; 2018 Oct; 15(10):. PubMed ID: 30309015
    [No Abstract]   [Full Text] [Related]  

  • 13. A national internet-linked based database for pediatric interstitial lung diseases: the French network.
    Nathan N; Taam RA; Epaud R; Delacourt C; Deschildre A; Reix P; Chiron R; de Pontbriand U; Brouard J; Fayon M; Dubus JC; Giovannini-Chami L; Bremont F; Bessaci K; Schweitzer C; Dalphin ML; Marguet C; Houdouin V; Troussier F; Sardet A; Hullo E; Gibertini I; Mahloul M; Michon D; Priouzeau A; Galeron L; Vibert JF; Thouvenin G; Corvol H; Deblic J; Clement A;
    Orphanet J Rare Dis; 2012 Jun; 7():40. PubMed ID: 22704798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].
    Busiah K; Drunat S; Vaivre-Douret L; Bonnefond A; Simon A; Flechtner I; Gérard B; Pouvreau N; Elie C; Nimri R; De Vries L; Tubiana-Rufi N; Metz C; Bertrand AM; Nivot-Adamiak S; de Kerdanet M; Stuckens C; Jennane F; Souchon PF; Le Tallec C; Désirée C; Pereira S; Dechaume A; Robert JJ; Phillip M; Scharfmann R; Czernichow P; Froguel P; Vaxillaire M; Polak M; Cavé H;
    Lancet Diabetes Endocrinol; 2013 Nov; 1(3):199-207. PubMed ID: 24622368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases.
    Baujat G; Choquet R; Bouée S; Jeanbat V; Courouve L; Ruel A; Michot C; Le Quan Sang KH; Lapidus D; Messiaen C; Landais P; Cormier-Daire V
    Orphanet J Rare Dis; 2017 Jun; 12(1):123. PubMed ID: 28666455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part].
    Seris A; Battistella M; Beylot-Barry M; Dalle S; Mortier L; Lebbé C; Blom A; Neidhart-Berard EM; Kramkimel N; Dupuy A; Zehou O; Dalac S; Jullie ML; Cribier B; Jouary T; ;
    Ann Dermatol Venereol; 2019 Nov; 146(11):704-710. PubMed ID: 31582261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Old and new long stay patients in French psychiatric institutions: results from a national random survey with two-year follow-up].
    Chapireau F
    Encephale; 2005; 31(4 Pt 1):466-76. PubMed ID: 16389714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ongoing French BaMaRa-BNDMR cohort: implementation and deployment of a nationwide information system on rare disease.
    Jannot AS; Messiaen C; Khatim A; Pichon T; Sandrin A;
    J Am Med Inform Assoc; 2022 Jan; 29(3):553-558. PubMed ID: 34741516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life among adults with diverse rare disorders.
    Bogart KR; Irvin VL
    Orphanet J Rare Dis; 2017 Dec; 12(1):177. PubMed ID: 29212508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.